Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Common Equity (2016 - 2025)

Harte Hanks (HHS) has disclosed Common Equity for 16 consecutive years, with $19.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 5.55% to $19.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $19.9 million, a 5.55% decrease, with the full-year FY2024 number at $21.7 million, up 9.23% from a year prior.
  • Common Equity was $19.9 million for Q3 2025 at Harte Hanks, down from $22.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $22.2 million in Q2 2025 to a low of -$54.4 million in Q1 2021.
  • A 5-year average of $1.9 million and a median of $19.9 million in 2025 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: fell 22.88% in 2021, then surged 260.33% in 2023.
  • Harte Hanks' Common Equity stood at -$24.7 million in 2021, then surged by 176.1% to $18.8 million in 2022, then rose by 5.58% to $19.9 million in 2023, then increased by 9.23% to $21.7 million in 2024, then dropped by 8.34% to $19.9 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Common Equity are $19.9 million (Q3 2025), $22.2 million (Q2 2025), and $21.4 million (Q1 2025).